Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

483 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Strong immunohistochemical expression of fibroblast growth factor receptor 3, superficial staining pattern of cytokeratin 20, and low proliferative activity define those papillary urothelial neoplasms of low malignant potential that do not recur.
Barbisan F, Santinelli A, Mazzucchelli R, Lopez-Beltran A, Cheng L, Scarpelli M, van der Kwast T, Montironi R. Barbisan F, et al. Cancer. 2008 Feb 1;112(3):636-44. doi: 10.1002/cncr.23212. Cancer. 2008. PMID: 18072261 Free article.
Interobserver variability between expert urologic pathologists for extraprostatic extension and surgical margin status in radical prostatectomy specimens.
Evans AJ, Henry PC, Van der Kwast TH, Tkachuk DC, Watson K, Lockwood GA, Fleshner NE, Cheung C, Belanger EC, Amin MB, Boccon-Gibod L, Bostwick DG, Egevad L, Epstein JI, Grignon DJ, Jones EC, Montironi R, Moussa M, Sweet JM, Trpkov K, Wheeler TM, Srigley JR. Evans AJ, et al. Among authors: van der kwast th. Am J Surg Pathol. 2008 Oct;32(10):1503-12. doi: 10.1097/PAS.0b013e31817fb3a0. Am J Surg Pathol. 2008. PMID: 18708939
DNA methylation of HOXD3 as a marker of prostate cancer progression.
Kron KJ, Liu L, Pethe VV, Demetrashvili N, Nesbitt ME, Trachtenberg J, Ozcelik H, Fleshner NE, Briollais L, van der Kwast TH, Bapat B. Kron KJ, et al. Among authors: van der kwast th. Lab Invest. 2010 Jul;90(7):1060-7. doi: 10.1038/labinvest.2010.57. Epub 2010 Mar 8. Lab Invest. 2010. PMID: 20212450 Free article.
Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi-institutional study.
Mir C, Shariat SF, van der Kwast TH, Ashfaq R, Lotan Y, Evans A, Skeldon S, Hanna S, Vajpeyi R, Kuk C, Alkhateeb S, Morote J, van Rhijn BW, Bostrom P, Yao J, Miyamoto H, Jewett M, Fleshner N, Messing E, Zlotta AR. Mir C, et al. Among authors: van rhijn bw, van der kwast th. BJU Int. 2011 Jul;108(1):24-30. doi: 10.1111/j.1464-410X.2010.09834.x. Epub 2010 Nov 10. BJU Int. 2011. PMID: 21070579
Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer.
Thoms J, Goda JS, Zlotta AR, Fleshner NE, van der Kwast TH, Supiot S, Warde P, Bristow RG. Thoms J, et al. Among authors: van der kwast th. Nat Rev Clin Oncol. 2011 Feb;8(2):107-13. doi: 10.1038/nrclinonc.2010.207. Epub 2010 Dec 21. Nat Rev Clin Oncol. 2011. PMID: 21178999 Review.
483 results